{"id":350441,"date":"2026-11-17T14:52:01","date_gmt":"2026-11-17T09:22:01","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=350441"},"modified":"2026-11-17T14:52:01","modified_gmt":"2026-11-17T09:22:01","slug":"digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/","title":{"rendered":"3 Digital IT Services Company, Drug Research and Manufacturing Company and Jewellery Retailer Stocks With a Strong Future Roadmap: Happiest Minds Technologies, Anthem Biosciences and Kalyan Jewellers India"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Happiest Minds Technologies, Anthem Biosciences and Kalyan Jewellers India: ROE of 12.6% to 21.4% and FY22 to FY26 revenue CAGR of 15.5% to 34.9%. Prices as of 16 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three <strong>digital IT, drug research and jewellery stocks<\/strong> to watch are <strong>Happiest Minds Technologies<\/strong>, <strong>Anthem Biosciences<\/strong> and <strong>Kalyan Jewellers India<\/strong>. Their <strong>return on equity<\/strong> ranges from <strong>12.6% to 21.4%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 15.5% to 34.9%. Kalyan Jewellers India leads on both return on equity at 21.4% and revenue growth at 34.9% a year. Prices are based on the 16 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Digital IT, drug research and jewellery stocks give investors a way to track businesses that sit close to everyday demand in India. Happiest Minds Technologies, Anthem Biosciences and Kalyan Jewellers India cover a digital IT services company, a drug research and manufacturing company and a jewellery retailer.<\/p>\n<p>This list covers three digital IT, drug research and jewellery stocks with complete current figures: Happiest Minds Technologies, Anthem Biosciences and Kalyan Jewellers India. Every figure comes from the latest reported financials and the 16 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#What_Are_Digital_IT_Drug_Research_and_Jewellery_Stocks\" title=\"What Are Digital IT, Drug Research and Jewellery Stocks?\">What Are Digital IT, Drug Research and Jewellery Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#Digital_IT_Drug_Research_and_Jewellery_Stocks_at_a_Glance\" title=\"Digital IT, Drug Research and Jewellery Stocks at a Glance\">Digital IT, Drug Research and Jewellery Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#Why_Do_Digital_IT_Drug_Research_and_Jewellery_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Digital IT, Drug Research and Jewellery Stocks Have a Strong Roadmap in India?\">Why Do Digital IT, Drug Research and Jewellery Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#Why_Happiest_Minds_Technologies_Features_Among_These_Digital_IT_Drug_Research_and_Jewellery_Stocks\" title=\"Why Happiest Minds Technologies Features Among These Digital IT, Drug Research and Jewellery Stocks\">Why Happiest Minds Technologies Features Among These Digital IT, Drug Research and Jewellery Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#Why_Anthem_Biosciences_Features_Among_These_Digital_IT_Drug_Research_and_Jewellery_Stocks\" title=\"Why Anthem Biosciences Features Among These Digital IT, Drug Research and Jewellery Stocks\">Why Anthem Biosciences Features Among These Digital IT, Drug Research and Jewellery Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#Why_Kalyan_Jewellers_India_Features_Among_These_Digital_IT_Drug_Research_and_Jewellery_Stocks\" title=\"Why Kalyan Jewellers India Features Among These Digital IT, Drug Research and Jewellery Stocks\">Why Kalyan Jewellers India Features Among These Digital IT, Drug Research and Jewellery Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#Happiest_Minds_Technologies_vs_Anthem_Biosciences_vs_Kalyan_Jewellers_India_on_Key_Financials\" title=\"Happiest Minds Technologies vs Anthem Biosciences vs Kalyan Jewellers India on Key Financials\">Happiest Minds Technologies vs Anthem Biosciences vs Kalyan Jewellers India on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#Key_Risks_to_Check_Before_Investing_in_Digital_IT_Drug_Research_and_Jewellery_Stocks\" title=\"Key Risks to Check Before Investing in Digital IT, Drug Research and Jewellery Stocks\">Key Risks to Check Before Investing in Digital IT, Drug Research and Jewellery Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#Final_Thoughts_on_Digital_IT_Drug_Research_and_Jewellery_Stocks\" title=\"Final Thoughts on Digital IT, Drug Research and Jewellery Stocks\">Final Thoughts on Digital IT, Drug Research and Jewellery Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#What_are_digital_IT_drug_research_and_jewellery_stocks\" title=\"What are digital IT, drug research and jewellery stocks?\">What are digital IT, drug research and jewellery stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#Which_digital_IT_drug_research_and_jewellery_stocks_are_covered_in_this_list\" title=\"Which digital IT, drug research and jewellery stocks are covered in this list?\">Which digital IT, drug research and jewellery stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#Why_do_digital_IT_drug_research_and_jewellery_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do digital IT, drug research and jewellery stocks have a strong future roadmap in India?\">Why do digital IT, drug research and jewellery stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#How_has_Happiest_Minds_Technologies_performed_financially\" title=\"How has Happiest Minds Technologies performed financially?\">How has Happiest Minds Technologies performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#How_has_Anthem_Biosciences_performed_financially\" title=\"How has Anthem Biosciences performed financially?\">How has Anthem Biosciences performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#How_has_Kalyan_Jewellers_India_performed_financially\" title=\"How has Kalyan Jewellers India performed financially?\">How has Kalyan Jewellers India performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#What_risks_should_investors_check_before_buying_digital_IT_drug_research_and_jewellery_stocks\" title=\"What risks should investors check before buying digital IT, drug research and jewellery stocks?\">What risks should investors check before buying digital IT, drug research and jewellery stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/digital-it-services-company-drug-research-and-manufacturing-company-and-jewellery-retailer-stocks-roadmap-grassland-list\/#Is_this_list_of_digital_IT_drug_research_and_jewellery_stocks_investment_advice\" title=\"Is this list of digital IT, drug research and jewellery stocks investment advice?\">Is this list of digital IT, drug research and jewellery stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Digital_IT_Drug_Research_and_Jewellery_Stocks\"><\/span><strong>What Are Digital IT, Drug Research and Jewellery Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Digital IT, drug research and jewellery stocks<\/strong> are listed companies that build digital and cloud solutions for global clients, develop and manufacture drugs and biologics for pharma partners, and sell gold and diamond jewellery through large stores. Their earnings depend on client technology budgets, outsourced drug work and festive jewellery demand.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Digital_IT_Drug_Research_and_Jewellery_Stocks_at_a_Glance\"><\/span><strong>Digital IT, Drug Research and Jewellery Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/happstmnds\/happiest-minds-technologies-ltd-share-price-today\">Happiest Minds Technologies<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">308.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,680<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.88<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/anthem\/anthem-biosciences-ltd-share-price-today\">Anthem Biosciences<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">931.45<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">45,546<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">79.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.02<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/kalyankjil\/kalyan-jewellers-india-ltd-share-price-today\">Kalyan Jewellers India<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">708.15<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">52,898<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">44.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.97<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Kalyan Jewellers India trades at a <strong>P\/E<\/strong> below the industry P\/E, while Happiest Minds Technologies and Anthem Biosciences trade above it, which reflects the growth the market already expects. Readers comparing digital IT, drug research and jewellery stocks should look at <strong>return on equity<\/strong> and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Digital_IT_Drug_Research_and_Jewellery_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Digital IT, Drug Research and Jewellery Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Digital IT, drug research and jewellery stocks have a strong roadmap in India because rising digital projects, growing outsourcing of drug development and steady jewellery buying in festivals and weddings keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Digital services.<\/strong> Clients modernise their systems.<\/li>\n<li><strong>Drug research.<\/strong> Pharma firms outsource development work.<\/li>\n<li><strong>Jewellery.<\/strong> Families buy gold for weddings and festivals.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Happiest_Minds_Technologies_Features_Among_These_Digital_IT_Drug_Research_and_Jewellery_Stocks\"><\/span><strong>Why Happiest Minds Technologies Features Among These Digital IT, Drug Research and Jewellery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the <strong>digital IT, drug research and jewellery stocks<\/strong> on this list, Happiest Minds Technologies is a Bengaluru-based digital transformation company that offers product engineering, digital business services and generative artificial intelligence solutions to clients across industries.<\/p>\n<p>In the June 2026 quarter, revenue grew 12.5% year on year to Rs 652 crore, while net profit rose 18.3% to Rs 67.6 crore. Revenue rose from Rs 1,131 crore in FY22 to Rs 2,400 crore in FY26, a compound annual growth rate of 20.7%.<\/p>\n<p>Net profit grew from Rs 185 crore in FY25 to Rs 213 crore in FY26, a rise of 15.1%. The company has a return on equity of 12.6%, a debt to equity ratio of 0.88 and a <strong>market capitalisation<\/strong> of Rs 4,680 crore. The stock trades at a <strong>P\/E<\/strong> of 21.0, above the industry P\/E of 17.9.<\/p>\n<p><strong>Roadmap:<\/strong> The company is adding capabilities in artificial intelligence, cloud and cybersecurity, which enterprises are prioritising. A digital-first positioning helps it win newer projects from established clients.<\/p>\n<p><strong>What to watch:<\/strong> Track the mix of digital business and product engineering revenue and new client additions.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Anthem_Biosciences_Features_Among_These_Digital_IT_Drug_Research_and_Jewellery_Stocks\"><\/span><strong>Why Anthem Biosciences Features Among These Digital IT, Drug Research and Jewellery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the digital engineering, contract research and gold jewellery shares on this list, Anthem Biosciences is a research-driven contract development and manufacturing organisation that serves global pharma and biotech customers with discovery, development and manufacturing services.<\/p>\n<p>The company has a return on equity of 19.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 45,546 crore. The stock trades at a P\/E of 79.1, above the industry P\/E of 36.0.<\/p>\n<p>Revenue rose from Rs 1,280 crore in FY22 to Rs 2,280 crore in FY26, a compound annual growth rate of 15.5%. Net profit grew from Rs 406 crore in FY22 to Rs 592 crore in FY26, which works out to a compound annual growth rate of 9.9%.<\/p>\n<p><strong>Roadmap:<\/strong> The company offers an integrated platform from discovery to commercial manufacturing, which makes it a partner for innovator clients. Its biologics, peptides and small-molecule services give it several routes to growth.<\/p>\n<p><strong>What to watch:<\/strong> Monitor the order pipeline from global customers and the ramp-up of newer manufacturing capacity.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Kalyan_Jewellers_India_Features_Among_These_Digital_IT_Drug_Research_and_Jewellery_Stocks\"><\/span><strong>Why Kalyan Jewellers India Features Among These Digital IT, Drug Research and Jewellery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Kalyan Jewellers India is a large jewellery retailer with showrooms across India and the Middle East, selling gold, diamond and studded jewellery under the Kalyan and Candere brands.<\/p>\n<p>Revenue rose from Rs 10,856 crore in FY22 to Rs 35,951 crore in FY26, a compound annual growth rate of 34.9%. Net profit grew from Rs 224 crore in FY22 to Rs 1,350 crore in FY26, which works out to a compound annual growth rate of 56.7%.<\/p>\n<p>In the June 2026 quarter, revenue grew 45.5% year on year to Rs 10,645 crore, while net profit rose 32.0% to Rs 349 crore. The company has a return on equity of 21.4%, a debt to equity ratio of 0.97 and a market capitalisation of Rs 52,898 crore. The stock trades at a P\/E of 36.9, below the industry P\/E of 44.3.<\/p>\n<p><strong>Roadmap:<\/strong> The company is opening showrooms in newer cities and growing its online jewellery arm. Strong brand recall and a franchise-led expansion model help it enter new regions at lower capital needs.<\/p>\n<p><strong>What to watch:<\/strong> Track same-store sales, new showroom additions and gold price movements.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Happiest_Minds_Technologies_vs_Anthem_Biosciences_vs_Kalyan_Jewellers_India_on_Key_Financials\"><\/span><strong>Happiest Minds Technologies vs Anthem Biosciences vs Kalyan Jewellers India on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three digital IT, drug research and jewellery stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Happiest Minds Technologies<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,131<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,400<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">213<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Anthem Biosciences<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,280<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,280<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">592<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">26.0%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Kalyan Jewellers India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10,856<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">35,951<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">34.9%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,350<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3.8%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Kalyan Jewellers India posts the highest return on equity in this group at 21.4%. Kalyan Jewellers India combines the largest FY26 revenue at Rs 35,951 crore with the fastest revenue growth, a 34.9% compound annual rate. A useful habit with digital IT, drug research and jewellery stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Digital_IT_Drug_Research_and_Jewellery_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Digital IT, Drug Research and Jewellery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these <strong>digital IT, drug research and jewellery stocks<\/strong>, the main points are: Long-term digital engineering, contract research and gold jewellery shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Client spending.<\/strong> Technology budgets can vary with global conditions.<\/li>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Pricing pressure.<\/strong> Generic prices can change by market.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter digital IT, drug research and jewellery stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Digital_IT_Drug_Research_and_Jewellery_Stocks\"><\/span><strong>Final Thoughts on Digital IT, Drug Research and Jewellery Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Digital IT, drug research and jewellery stocks work best when investors track growth, valuation and return on equity side by side. Happiest Minds Technologies, Anthem Biosciences and Kalyan Jewellers India each have a clear plan to grow. Based on the 16 November 2026 close, Happiest Minds Technologies trades at Rs 308.5, Anthem Biosciences at Rs 931.45 and Kalyan Jewellers India at Rs 708.15. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these <strong>digital IT, drug research and jewellery stocks<\/strong> to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track digital IT, drug research and jewellery stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_digital_IT_drug_research_and_jewellery_stocks\"><\/span><strong>What are digital IT, drug research and jewellery stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Digital IT, drug research and jewellery stocks are listed companies that build digital and cloud solutions for global clients, develop and manufacture drugs and biologics for pharma partners, and sell gold and diamond jewellery through large stores. Their earnings depend on client technology budgets, outsourced drug work and festive jewellery demand. This list looks at three of them, Happiest Minds Technologies, Anthem Biosciences and Kalyan Jewellers India, using reported FY22 to FY26 financials and the 16 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_digital_IT_drug_research_and_jewellery_stocks_are_covered_in_this_list\"><\/span><strong>Which digital IT, drug research and jewellery stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Happiest Minds Technologies, Anthem Biosciences and Kalyan Jewellers India. Based on the 16 November 2026 close, Happiest Minds Technologies traded at Rs 308.5, Anthem Biosciences at Rs 931.45 and Kalyan Jewellers India at Rs 708.15. Their return on equity ranges from <strong>12.6% to 21.4%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 15.5% to 34.9%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_digital_IT_drug_research_and_jewellery_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do digital IT, drug research and jewellery stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Digital IT, drug research and jewellery stocks have a strong roadmap in India because rising digital projects, growing outsourcing of drug development and steady jewellery buying in festivals and weddings keep widening the market for these companies. The main drivers are as follows. Digital services. Clients modernise their systems. Drug research. Pharma firms outsource development work. Jewellery. Families buy gold for weddings and festivals. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Happiest_Minds_Technologies_performed_financially\"><\/span><strong>How has Happiest Minds Technologies performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,131 crore in FY22 to Rs 2,400 crore in FY26, a compound annual growth rate of 20.7%. Net profit grew from Rs 185 crore in FY25 to Rs 213 crore in FY26, a rise of 15.1%. In the June 2026 quarter, revenue grew 12.5% year on year to Rs 652 crore, while net profit rose 18.3% to Rs 67.6 crore. The company has a return on equity of 12.6%, a debt to equity ratio of 0.88 and a market capitalisation of Rs 4,680 crore. The stock trades at a P\/E of 21.0, above the industry P\/E of 17.9. Looking ahead, the company is adding capabilities in artificial intelligence, cloud and cybersecurity, which enterprises are prioritising. A digital-first positioning helps it win newer projects from established clients.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Anthem_Biosciences_performed_financially\"><\/span><strong>How has Anthem Biosciences performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,280 crore in FY22 to Rs 2,280 crore in FY26, a compound annual growth rate of 15.5%. Net profit grew from Rs 406 crore in FY22 to Rs 592 crore in FY26, which works out to a compound annual growth rate of 9.9%. The company has a return on equity of 19.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 45,546 crore. The stock trades at a P\/E of 79.1, above the industry P\/E of 36.0. Looking ahead, the company offers an integrated platform from discovery to commercial manufacturing, which makes it a partner for innovator clients. Its biologics, peptides and small-molecule services give it several routes to growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Kalyan_Jewellers_India_performed_financially\"><\/span><strong>How has Kalyan Jewellers India performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 10,856 crore in FY22 to Rs 35,951 crore in FY26, a compound annual growth rate of 34.9%. Net profit grew from Rs 224 crore in FY22 to Rs 1,350 crore in FY26, which works out to a compound annual growth rate of 56.7%. In the June 2026 quarter, revenue grew 45.5% year on year to Rs 10,645 crore, while net profit rose 32.0% to Rs 349 crore. The company has a return on equity of 21.4%, a debt to equity ratio of 0.97 and a market capitalisation of Rs 52,898 crore. The stock trades at a P\/E of 36.9, below the industry P\/E of 44.3. Looking ahead, the company is opening showrooms in newer cities and growing its online jewellery arm. Strong brand recall and a franchise-led expansion model help it enter new regions at lower capital needs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_digital_IT_drug_research_and_jewellery_stocks\"><\/span><strong>What risks should investors check before buying digital IT, drug research and jewellery stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying <strong>digital IT, drug research and jewellery stocks<\/strong>. Client spending. Technology budgets can vary with global conditions. Regulatory approvals. Plant inspections and approvals can affect supplies. Pricing pressure. Generic prices can change by market. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_digital_IT_drug_research_and_jewellery_stocks_investment_advice\"><\/span><strong>Is this list of digital IT, drug research and jewellery stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 16 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are digital IT, drug research and jewellery stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Digital IT, drug research and jewellery stocks are listed companies that build digital and cloud solutions for global clients, develop and manufacture drugs and biologics for pharma partners, and sell gold and diamond jewellery through large stores. Their earnings depend on client technology budgets, outsourced drug work and festive jewellery demand. This list looks at three of them, Happiest Minds Technologies, Anthem Biosciences and Kalyan Jewellers India, using reported FY22 to FY26 financials and the 16 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which digital IT, drug research and jewellery stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Happiest Minds Technologies, Anthem Biosciences and Kalyan Jewellers India. Based on the 16 November 2026 close, Happiest Minds Technologies traded at Rs 308.5, Anthem Biosciences at Rs 931.45 and Kalyan Jewellers India at Rs 708.15. Their return on equity ranges from 12.6% to 21.4%, and their revenue compound annual growth from FY22 to FY26 ranges from 15.5% to 34.9%.\"}},{\"@type\":\"Question\",\"name\":\"Why do digital IT, drug research and jewellery stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Digital IT, drug research and jewellery stocks have a strong roadmap in India because rising digital projects, growing outsourcing of drug development and steady jewellery buying in festivals and weddings keep widening the market for these companies. The main drivers are as follows. Digital services. Clients modernise their systems. Drug research. Pharma firms outsource development work. Jewellery. Families buy gold for weddings and festivals. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Happiest Minds Technologies performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,131 crore in FY22 to Rs 2,400 crore in FY26, a compound annual growth rate of 20.7%. Net profit grew from Rs 185 crore in FY25 to Rs 213 crore in FY26, a rise of 15.1%. In the June 2026 quarter, revenue grew 12.5% year on year to Rs 652 crore, while net profit rose 18.3% to Rs 67.6 crore. The company has a return on equity of 12.6%, a debt to equity ratio of 0.88 and a market capitalisation of Rs 4,680 crore. The stock trades at a P\/E of 21.0, above the industry P\/E of 17.9. Looking ahead, the company is adding capabilities in artificial intelligence, cloud and cybersecurity, which enterprises are prioritising. A digital-first positioning helps it win newer projects from established clients.\"}},{\"@type\":\"Question\",\"name\":\"How has Anthem Biosciences performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,280 crore in FY22 to Rs 2,280 crore in FY26, a compound annual growth rate of 15.5%. Net profit grew from Rs 406 crore in FY22 to Rs 592 crore in FY26, which works out to a compound annual growth rate of 9.9%. The company has a return on equity of 19.4%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 45,546 crore. The stock trades at a P\/E of 79.1, above the industry P\/E of 36.0. Looking ahead, the company offers an integrated platform from discovery to commercial manufacturing, which makes it a partner for innovator clients. Its biologics, peptides and small-molecule services give it several routes to growth.\"}},{\"@type\":\"Question\",\"name\":\"How has Kalyan Jewellers India performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 10,856 crore in FY22 to Rs 35,951 crore in FY26, a compound annual growth rate of 34.9%. Net profit grew from Rs 224 crore in FY22 to Rs 1,350 crore in FY26, which works out to a compound annual growth rate of 56.7%. In the June 2026 quarter, revenue grew 45.5% year on year to Rs 10,645 crore, while net profit rose 32.0% to Rs 349 crore. The company has a return on equity of 21.4%, a debt to equity ratio of 0.97 and a market capitalisation of Rs 52,898 crore. The stock trades at a P\/E of 36.9, below the industry P\/E of 44.3. Looking ahead, the company is opening showrooms in newer cities and growing its online jewellery arm. Strong brand recall and a franchise-led expansion model help it enter new regions at lower capital needs.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying digital IT, drug research and jewellery stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying digital IT, drug research and jewellery stocks. Client spending. Technology budgets can vary with global conditions. Regulatory approvals. Plant inspections and approvals can affect supplies. Pricing pressure. Generic prices can change by market. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of digital IT, drug research and jewellery stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 16 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Digital IT, Drug Research and Jewellery Stocks with a strong future roadmap: Happiest Minds Technologies, Anthem Biosciences and Kalyan Jewellers India. Compare price, valuation, return on equity and revenue growth as of 16 November 2026.<\/p>\n","protected":false},"author":34,"featured_media":350440,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[9113,3803,25037,19115,25036,16103,25034,25035,9364,15733],"class_list":["post-350441","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-anthem-biosciences","tag-best-stocks","tag-biotech-manufacturing-and-jewellery-retail-stocks","tag-cloud-services","tag-contract-research-and-gold-jewellery-shares","tag-digital-engineering","tag-digital-it","tag-drug-research-and-jewellery-stocks","tag-happiest-minds-technologies","tag-kalyan-jewellers-india"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["350440"],"rank_math_title":["Digital IT, Drug Research and Jewellery Stocks"],"rank_math_description":["Compare 3 digital IT, drug research and jewellery stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 16 Nov 2026."],"rank_math_focus_keyword":["digital IT, drug research and jewellery stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-digital-it-services-company-drug-research-and-manufacturing-company-and.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/350441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=350441"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/350441\/revisions"}],"predecessor-version":[{"id":350442,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/350441\/revisions\/350442"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/350440"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=350441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=350441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=350441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}